Modification of cardiovascular risk in hemodialysis patients: An evidence-based review.
Johnson DW, Craven AM, Isbel NM. Hemodial Int. 2007 Jan;11(1):1-14
Related Articles:
- Effect of Angiotensin Receptor Blockers on Cardiovascular Events in Patients Undergoing Hemodialysis: An Open-Label Randomized Controlled Trial.
- Diagnostic Thresholds for Ambulatory Blood Pressure Monitoring Based on 10-Year Cardiovascular Risk.
- Treatment of Anemia in Chronic Kidney Disease — Strategies Based on Evidence
Recent Comments